Neuberger Berman Group LLC Cel Sci Corp Transaction History

Neuberger Berman Group LLC

  • $123 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

May 13, 2021
SELL
$12.0 - $27.64 $4.05 Million - $9.33 Million
-337,459 Closed
0 $0
Q3 2020

Nov 12, 2020
BUY
$11.69 - $14.54 $3.59 Million - $4.46 Million
306,760 Added 999.25%
337,459 $4.3 Million
Q2 2020

Aug 13, 2020
BUY
$9.75 - $17.6 $299,315 - $540,302
30,699 New
30,699 $458,000

Others Institutions Holding CVM

# of Institutions
71
Shares Held
6M
Call Options Held
27.1K
Put Options Held
150K
View Full List

About CEL SCI CORP

CVM Quotes by TradingView
  • Ticker CVM
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 43,367,500
  • Market Cap $26.9M
  • Description
  • CEL-SCI Corporation engages in the research and development of immunotherapy for the treatment of cancer and infectious diseases. The company's lead investigational immunotherapy is Multikine, which is under phase III clinical trial for the treatment of head and neck cancer. Its Ligand Epitope Antigen Presentation System (LEAPS), a pre-clinical ...
More about CVM
Track This Portfolio

Track Neuberger Berman Group LLC Portfolio

Follow Neuberger Berman Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Neuberger Berman Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Neuberger Berman Group LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email